138 related articles for article (PubMed ID: 10487493)
21. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687
[TBL] [Abstract][Full Text] [Related]
22. Measurement of human plasma phospholipid transfer protein by sandwich ELISA.
Oka T; Kujiraoka T; Ito M; Nagano M; Ishihara M; Iwasaki T; Egashira T; Miller NE; Hattori H
Clin Chem; 2000 Sep; 46(9):1357-64. PubMed ID: 10973866
[TBL] [Abstract][Full Text] [Related]
23. ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response.
Barlage S; Fröhlich D; Böttcher A; Jauhiainen M; Müller HP; Noetzel F; Rothe G; Schütt C; Linke RP; Lackner KJ; Ehnholm C; Schmitz G
J Lipid Res; 2001 Feb; 42(2):281-90. PubMed ID: 11181759
[TBL] [Abstract][Full Text] [Related]
24. Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio.
Albers JJ; Tu AY; Paigen B; Chen H; Cheung MC; Marcovina SM
Int J Clin Lab Res; 1996; 26(4):262-7. PubMed ID: 9007618
[TBL] [Abstract][Full Text] [Related]
25. Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases.
Yatsuya H; Tamakoshi K; Hattori H; Otsuka R; Wada K; Zhang H; Mabuchi T; Ishikawa M; Murata C; Yoshida T; Kondo T; Toyoshima H
Circ J; 2004 Jan; 68(1):11-6. PubMed ID: 14695459
[TBL] [Abstract][Full Text] [Related]
26. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
[TBL] [Abstract][Full Text] [Related]
27. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice.
van Haperen R; van Tol A; Vermeulen P; Jauhiainen M; van Gent T; van den Berg P; Ehnholm S; Grosveld F; van der Kamp A; de Crom R
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1082-8. PubMed ID: 10764677
[TBL] [Abstract][Full Text] [Related]
28. Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients.
Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
Diabetes; 1999 Aug; 48(8):1631-7. PubMed ID: 10426383
[TBL] [Abstract][Full Text] [Related]
29. Pig plasma phospholipid transfer protein facilitates HDL interconversion.
Pussinen P; Jauhianinen M; Metso J; Tyynelä J; Ehnholm C
J Lipid Res; 1995 May; 36(5):975-85. PubMed ID: 7658169
[TBL] [Abstract][Full Text] [Related]
30. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion.
Huuskonen J; Olkkonen VM; Ehnholm C; Metso J; Julkunen I; Jauhiainen M
Biochemistry; 2000 Dec; 39(51):16092-8. PubMed ID: 11123937
[TBL] [Abstract][Full Text] [Related]
31. A hydrophobic cluster at the surface of the human plasma phospholipid transfer protein is critical for activity on high density lipoproteins.
Desrumaux C; Labeur C; Verhee A; Tavernier J; Vandekerckhove J; Rosseneu M; Peelman F
J Biol Chem; 2001 Feb; 276(8):5908-15. PubMed ID: 11083872
[TBL] [Abstract][Full Text] [Related]
32. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate.
Bouly M; Masson D; Gross B; Jiang XC; Fievet C; Castro G; Tall AR; Fruchart JC; Staels B; Lagrost L; Luc G
J Biol Chem; 2001 Jul; 276(28):25841-7. PubMed ID: 11342537
[TBL] [Abstract][Full Text] [Related]
33. Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
Dullaart RPF; Gruppen EG; Dallinga-Thie GM
Clin Biochem; 2016 Apr; 49(6):508-510. PubMed ID: 26656640
[TBL] [Abstract][Full Text] [Related]
34. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
Yang XP; Yan D; Qiao C; Liu RJ; Chen JG; Li J; Schneider M; Lagrost L; Xiao X; Jiang XC
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1601-7. PubMed ID: 12855484
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.
Lie J; de Crom R; Jauhiainen M; van Gent T; van Haperen R; Scheek L; Jansen H; Ehnholm C; van Tol A
Biochem J; 2001 Dec; 360(Pt 2):379-85. PubMed ID: 11716766
[TBL] [Abstract][Full Text] [Related]
36. Effects of weight loss on PLTP activity and HDL particle size.
Kaser S; Laimer M; Sandhofer A; Salzmann K; Ebenbichler CF; Patsch JR
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1280-2. PubMed ID: 15365582
[TBL] [Abstract][Full Text] [Related]
37. Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample.
Jänis MT; Siggins S; Tahvanainen E; Vikstedt R; Silander K; Metso J; Aromaa A; Taskinen MR; Olkkonen VM; Jauhiainen M; Ehnholm C
J Lipid Res; 2004 Dec; 45(12):2303-9. PubMed ID: 15342679
[TBL] [Abstract][Full Text] [Related]
38. Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity.
Schneider M; Vergès B; Klein A; Miller ER; Deckert V; Desrumaux C; Masson D; Gambert P; Brun JM; Fruchart-Najib J; Blache D; Witztum JL; Lagrost L
Diabetes; 2004 Oct; 53(10):2633-9. PubMed ID: 15448094
[TBL] [Abstract][Full Text] [Related]
39. Introduction of the human PLTP transgene suppresses the atherogenic diet-induced increase in plasma phospholipid transfer activity in C57BL/6 mice.
Tu AY; Paigen B; Wolfbauer G; Cheung MC; Kennedy H; Chen H; Albers JJ
Int J Clin Lab Res; 1999; 29(1):14-21. PubMed ID: 10356658
[TBL] [Abstract][Full Text] [Related]
40. Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion.
Pussinen PJ; Malle E; Metso J; Sattler W; Raynes JG; Jauhiainen M
Atherosclerosis; 2001 Apr; 155(2):297-305. PubMed ID: 11254899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
